9th Circ. Refuses To Rehear Pfizer-Wyeth Merger Suit

Law360, New York (June 14, 2011, 5:58 PM EDT) -- A group of pharmacies last week lost a bid to have the Ninth Circuit reconsider the dismissal of a suit alleging the $68 billion merger of Pfizer Inc. and Wyeth in 2009 raised prices and hurt competition in the pharmaceutical market.

The Ninth Circuit issued an order June 7 refusing to reconsider its May ruling upholding the dismissal of the suit, saying the complaint failed to support allegations of “significant anti-competitive effects."

The seven plaintiffs, including Golden Gate Pharmacy Services Inc., Marin Apothecaries and Pediatric Care...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.